US Patent Issued to MEMORIAL SLOAN-KETTERING CANCER CENTER on Oct. 7 for "Methods for treating neuroblastoma with combination therapy" (New York Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,156, issued on Oct. 7, was assigned to MEMORIAL SLOAN-KETTERING CANCER CENTER (New York).

"Methods for treating neuroblastoma with combination therapy" was invented by Shakeel Modak (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating neuroblastoma using an anti-GD2 antibody, at least one chemotherapeutic agent, and at least one hematopoietic growth factor. The present disclosure also provides compositions for treating neuroblastoma."

The patent was filed on Feb. 22, 2021, under Application No. 17/181,321.

*For further information, including images, charts and tables, please visit: http://patf...